What is Sana Biotechnology's AOCI?

Sana Biotechnology (SANA) reported AOCI of -$2K in Q1 2026.

What is the long-term trend for Sana Biotechnology's AOCI?

Over 5 years (2020 to 2025), Sana Biotechnology's AOCI has grown at a -1.4% compound annual growth rate (CAGR), from $30K to $28K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Sana Biotechnology SANA AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Gilead SciencesGILD

$78M-15.2%

CRISPR TherapeuticsCRSP

-$1.94M-147%

Cullinan Therapeutics, Inc.CGEM

$127K-74.9%

Intellia TherapeuticsNTLA

-$240K-123%

Other financials

Income statement

See full

Operating income-$48.6M+4.0%

Net income-$47.2M+4.4%

EPS (diluted)-$0.17+19.0%

Balance sheet

See full

Cash & equivalents$83.8M-12.8%

Total debt$75.3M-17.5%

Total equity$119.2M-43.0%

Total assets$373.6M-16.1%

Cash flow

See full

Operating cash flow-$37.4M+23.2%

CapEx$288.0K+112%

Free cash flow-$37.7M+22.8%

Valuation

See full

Market cap$907.23M+54.1%

Enterprise value$898.76M+53.9%

Returns & leverage

See full

Return on equity-147.4%-2,468pp

Debt / equity0.6×+0.2×

Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sana Biotechnology's AOCI?: Sana Biotechnology (SANA) reported AOCI of -$2K in Q1 2026.
What is the long-term trend for Sana Biotechnology's AOCI?: Over 5 years (2020 to 2025), Sana Biotechnology's AOCI has grown at a -1.4% compound annual growth rate (CAGR), from $30K to $28K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.